Prevalence and risk factors related to infections of cardiac resynchronization therapy devices

European Heart Journal

Volumn 31, Issue 2, 2010, Pages 203-210

  Romeyer Bouchard, Cécile ^a   Da Costa, Antoine ^a,d   Dauphinot, Virginie ^b   Messier, Marc ^c   Bisch, Laurence ^a   Samuel, Bernard ^a   Lafond, Patrick ^a   Ricci, Philippe ^a   Isaaz, Karl ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^d HÔPITAL NORD   (France)

Author keywords

Cardiac resynchronization; Infection; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEVICE INFECTION; DIALYSIS; ENDOCARDITIS; FEMALE; HEMATOMA; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QRS COMPLEX; REOPERATION; RISK FACTOR; SEPTICEMIA; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; ENDOCARDITIS, BACTERIAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 74549172877     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp421     Document Type: Article

References (43)

1. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-608.
2. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098-2107.
3. Klug D, Wallet F, Lacroix D, Marquié C, Kouakam C, Kacet S, Courcol M. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 2004;90:882-886.
4. Uslan DZ, Sohail MR, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Baddour M. Frequency of permanent pacemaker or implantable cardioverter- defibrillator infection in patients with gram-negative bacteraemia. Clin Infect Dis 2006;43:731-736.
5. Chua JD, Wilkoff BL, Lee I, Jurati N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Arch Intern Med 2000;133:604-608.
6. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-348.
7. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, St Sauver JL, Wilson WR, Baddour LM. Age-and sex-associated trends in bloodstream infection. A Population-Based Study in Olmsted County, Minnesota. Arch Intern Med 2007; 167:834-839.
8. Uslan DZ, Sohail MRS, Sauver JR, Friedman PA, Hayes DL, Stoner SM, Wilson WR, Steckelberg JM, Baddour LM. Defibrillator infection a population-based study. Arch Intern Med 2007;167:669-675.
9. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48: 590-591.
10. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S For the PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116:1349-1355.
11. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, Pavie A, Piette JC, Grandjbakhch I. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-484.
12. Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand J Infect Dis 2004;36:674-679.
13. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, Isaaz K, Touboul P. Role of the preaxillary flora in pacemaker infections. A prospective study. Circulation 1998;97:1791-1795.
14. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, Masselink LE, Kaye KS, Corey GR, Reller LB, Stryjewski ME, Schulman KA, Fowler VG. Staphylococcus aureus bacteraemia in patients with prosthetic devices: costs and outcomes. Am J Med 2005;118:1416.
15. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350:1422-1429.
16. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller B, Vance G. Staphylococcus aureus bacteraemia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104:1029-1033.
17. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-1801.
18. behalf of the Italian network on congestive heart failure investigators. Left-bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
19. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Mabo P, Lazarus A, Ritter P, Mc Kenna W, Daubert JC. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
20. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomised controlled trials. J Am Med Assoc 2003;289:730-740.
21. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kokovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
22. Knight BP, Desai A, Coman J, Faddis M, Yong P. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:72-77.
23. Leclercq C, Cazeau S, Lellouche D, Fossati F, Anselme F, Davy JM, Sadoul N, Klug D, Mollo L, Daubert JC. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF study. Pacing Clin Electrophysiol 2007;1:S23-S30.
24. Romeyer-Bouchard C, Da Costa A, Abdellaoui L, Messier M, Thevenin J, Afif Z, Samuel B, Kihel A, Cerisier A, Convert G, Isaaz K. Simplified cardiac resynchro-nization implantation technique involving right access and a triple-guide/single introducer approach. Heart Rhythm 2005;2:714-719.
25. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med 1994;96:200-209.
26. Leon RA, Abraham WT, Curtis AB et al. Safety of transvenous cardiac resynchro-nization system implantation in patients with chronic heart failure: combined results of over 2000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348-2356.
27. Kautzner J, Riedlbauchová L, Cihák R, Bytesńik J, Vancura V. Technical aspects of implantation of LV lead for cardiac resynchronization therapy in chronic heart failure. Pacing Clinical Electrophysiol 2004;27:783-790.
28. Daoud EG, Kalbfleisch SJ, Hummel JD, Weiss R, Augustini RS, Duff SB, Polsinelli G, Castor J, Meta T. Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators. J Cardiovasc Electrophy-siol 2002;13:964-970.
29. Alonso C, Leclercq C, Revault d'Allonnes F, Pavin D, Victor F, Mabo P, Daubert J-C. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86:405-410.
30. Sohail MR, Uslan DZ, Khan A, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker. Clin Infect Dis 2007;45:166-173.
31. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pace 2006;29:142-145.
32. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K, Lim P, Patel D, Callahan T, Martin DO, Arruda M, Schweikert RA, Saliba WI, Wilkoff B, Natale A. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol 2008;19: 1259-1265.
33. Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowki EN. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008;19:266-268.
34. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. J Am Med Assoc 2006;295:1907-1911.
35. Tsai V, Chen H, Hsia H, Zei P, Wang P, Al-Ahmad A. Cardiac device infections complicated by erosion. J Interv Card Electrophysiol 2007;19:133-137.
36. Al-Khadra AS. Implantation of pacemakers and implantable cardioverter defibril-lators in orally anticoagulant patients. Pace 2003;26:511-514.
37. Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, Trillot N, Lacroix D, Kacet S. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace 2006;8:283-287.
38. Wiegand UK, Lejeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F. Pocket hematoma after pacemaker or implantable cardio-verter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004;126: 1177-1186.
39. Kapa S, Hyberger L, Rea RF, Hayes DL. Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pace 2007;30: 730-733.
40. Gil P, Fernández Guerrero ML, Bayona JF, Rubio JM, de Gó rgolas M, Granizo JJ, Farré J. Infections of implantable cardioverter defibrillators: frequency, predisposing factors and clinical significance. Clin Microbiol Infect 2006;12:533-537.
41. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure (The Cardiac Resynchronization-Heart Failure [CARE-HF] trial extension phase). Eur Heart J 2006;27:1928-1932.
42. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
43. Harell F, Lee K. Regression modeling strategies for improved prediction. Stat Med 1984;3:143-152.